Kiadis Pharma strengthens core team with three senior appointments

Amsterdam, The Netherlands, November 8, 2018 – Kiadis Pharma N.V. (“Kiadis Pharma” or the “Company”) (Euronext Amsterdam and Brussels: KDS), a clinical-stage biopharmaceutical company, today announces that it has appointed three new senior team members to further strengthen the Company as it transitions into commercial stage. Mr. Dirk De Naeyer has been appointed Head of Supply Chain, Mr. Jonathan Sweeting has been appointed Head of Commercial Europe and Mr. Marcel Zwaal has been appointed Head of Corporate Development.
Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...